| Clinical data | |
|---|---|
| Other names | ARV-110 |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C41H43ClFN9O6 |
| Molar mass | 812.30 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Bavdegalutamide is an experimentalproteolysis targeting chimera that functions as aandrogen receptor degrader.[1] It is being developed to treatmetastatic castration-resistant prostate cancer.[2][3][4]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |